Our paper on how nucleosomes influence mutation rate leading to a 10bp periodic pattern is out in Cell

By |2023-11-08T09:54:27+00:00November 7th, 2018|Categories: BG News, Uncategorized|Tags: , , , , , |

We are very excited to share that our work describing the somatic and germline 10bp periodicity in the mutation rate within nucleosome-bound DNA was published in the [...]

Comments Off on Our paper on how nucleosomes influence mutation rate leading to a 10bp periodic pattern is out in Cell

Introducing the Cancer Genome Interpreter

By |2023-11-08T09:54:27+00:00March 30th, 2018|Categories: Uncategorized|

This is a post written by Abel, Carlota, David and Nuria for BioMed Central blog network Cancer Genome Interpreter (CGI) is an open platform designed to support the [...]

Comments Off on Introducing the Cancer Genome Interpreter

Our paper on reduced mutation rate in exons due to differential mismatch repair published in Nature Genetics

By |2023-11-08T09:54:27+00:00November 7th, 2017|Categories: BG News, Uncategorized|

We are happy to announce that our paper on reduced mutation burden in exons caused by differential mismatch repair has been published yesterday, 6th November in Nature [...]

Comments Off on Our paper on reduced mutation rate in exons due to differential mismatch repair published in Nature Genetics

Alba is a PhD!

By |2023-11-08T09:54:29+00:00May 7th, 2013|Categories: Uncategorized|

Last Monday, April 29th, Alba defended her PhD thesis at the PRBB. It was the highest point of a story that started some five years ago, when [...]

Comments Off on Alba is a PhD!

Sample Level Enrichment Analysis (SLEA) in Gitools to assess the transcriptional status of pathways per tumor

By |2023-11-08T09:54:31+00:00February 21st, 2012|Categories: BioinfoTips, Uncategorized|Tags: , |

The identification of molecular biomarkers from expression data is a major objective in cancer research. It is clear that there is a benefit in pathway [...]

Comments Off on Sample Level Enrichment Analysis (SLEA) in Gitools to assess the transcriptional status of pathways per tumor
Go to Top